Moreover, downregulation of endogenous miR-128a resulted in re-sensitization of the aromatase inhibitor-resistant breast cancer cell line to the growth inhibitory effect of TGFβ [204]. This evidence concerns the gene CYP19A1 and breast carcinoma.